CVS Health Corp Earnings, Revenue Beat in Q2 By

© Reuters. CVS Well being Corp Earnings, Income Beat in Q2 – CVS Well being Corp (NYSE:) reported on Wednesday second quarter that beat analysts’ forecasts and income that topped expectations.

CVS Well being Corp introduced earnings per share of $2.42 on income of $72.62B. Analysts polled by anticipated EPS of $2.06 on income of $70.14B.

CVS Well being Corp shares are up 22% from the start of the 12 months, nonetheless down 7.30% from its 52 week excessive of $90.61 set on Could 24. They’re outperforming the S&P 500 which is up 17.76% from the beginning of the 12 months.

CVS Well being Corp follows different main Healthcare sector earnings this month

CVS Well being Corp’s report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on income of $23.31B, in comparison with forecasts EPS of $2.29 on income of $22.49B.

UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on income of $71.32B, in comparison with forecast for EPS of $4.43 on income of $69.51B.

Keep up-to-date on all the upcoming earnings reviews by visiting’s earnings calendar

Disclaimer: Fusion Media wish to remind you that the info contained on this web site just isn’t essentially real-time nor correct. All CFDs (shares, indexes, futures) and Foreign exchange costs usually are not offered by exchanges however moderately by market makers, and so costs might not be correct and will differ from the precise market value, that means costs are indicative and never acceptable for buying and selling functions. Subsequently Fusion Media doesn`t bear any duty for any buying and selling losses you would possibly incur because of utilizing this knowledge.

Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or harm because of reliance on the data together with knowledge, quotes, charts and purchase/promote indicators contained inside this web site. Please be absolutely knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is likely one of the riskiest funding varieties attainable.

Source link